Myeloid Neoplasm Mutation Analysis Only : 1016478

Test Code

MDFCPMYLSEQ or 1016478

CPT Codes
81450

Includes

Includes: ASXL1, CALR, CBL, CEBPA, CSF3R, DNMT3A, ETV6, EZH2, FLT3, IDH1, IDH2, JAK2, KIT, KRAS, MPL, NPM1, NRAS, PHF6, PTEN, RUNX1, SETBP1, SF3B1, SRSF2, TET2, TP53, U2AF1, WT1

Instructions

Peripheral Blood in a lavender top (EDTA) tube and/or a green top sodium heparin tube.

OR

Bone Marrow in a lavender top (EDTA) tube and/or a green top sodium heparin tube.

Transport Container

Peripheral Blood in a lavender top (EDTA) tube and/or a green top sodium heparin tube.

OR

Bone Marrow in a lavender top (EDTA) tube and/or a green top sodium heparin tube.

Transport Temperature

Refrigerated.

Specimen Stability

Ambient: 48 hours; Refrigerated: 15 days; Frozen: Unacceptable

Methodology
Next Generation Sequencing, PCR and Fragment Analysis, and for CEBPA only Next Generation Sequencing at Quest Diagnostics San Juan Capistrano Laboratory

Setup Schedule

Monday & Wednesday & Friday

Report Available

10-14 days

Reference Range

Mutation not detected.

Clinical Significance

The Myeloid Neoplasm Mutation Only panel aids in the diagnosis, prognosis and treatment of patients with unspecified myeloid lineage neoplasms, chronic myelomonocytic leukemia (CMML), or myelodysplastic/myeloproliferative (MDS/MPN) neoplasm overlap sydromes.

Performing Laboratory
med fusion; CEBPA Quest SJC

The CPT Codes provided in this document are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed. Any Profile/panel component may be ordered separately. Reflex tests are performed at an additional charge.